Financhill
Back

Inhibrx Biosciences, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison

Sell
44

INBX
Inhibrx Biosciences, Inc.

Last Price:
$76.07
Seasonality Move:
-8.44%
Buy
70

NBY
NovaBay Pharmaceuticals, Inc.

Last Price:
$5.72
Seasonality Move:
13.91%
Sell
44
Inhibrx Biosciences, Inc. (INBX) is a Sell

Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?

  • The current Inhibrx Biosciences, Inc. [INBX] share price is $79.00. The Score for INBX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
NovaBay Pharmaceuticals, Inc. (NBY) is a Buy

Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $5.64. The Score for NBY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INBX Stock Price Chart

What is Inhibrx Biosciences, Inc.'s stock price today?

  • The Inhibrx Biosciences, Inc. share price today is $79.00
    The current trend is moderately bearish and INBX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals, Inc.'s stock price today?

  • The NovaBay Pharmaceuticals, Inc. share price today is $5.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.

INBX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 48.22 Sell
Chaikin Money Flow: 95108 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.04 - 87.1) Sell
Bollinger Bands (100): (27.43 - 79.25) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.11 Buy
Relative Strength Index (14 RSI): 71.51 Buy
Chaikin Money Flow: -26466 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.22 - 4.68) Buy
Bollinger Bands (100): (0.58 - 3.08) Buy

INBX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.07 Sell
20-day SMA: 83.16 Sell
50-day SMA: 77.38 Buy
200-day SMA: 34.4 Buy
8-day EMA: 80.28 Sell
20-day EMA: 81.12 Sell
50-day EMA: 73.58 Buy
200-day EMA: 43.75 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.2 Buy
20-day SMA: 3.43 Buy
50-day SMA: 2.03 Buy
200-day SMA: 1.21 Buy
8-day EMA: 5 Buy
20-day EMA: 3.82 Buy
50-day EMA: 2.49 Buy
200-day EMA: 0.97 Buy

Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.

NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

Inhibrx Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):